Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05144542

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

The Potential Risks and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

This clinical trial investigates the effects of switching from smoking regular cigarettes to electronic cigarettes (e-cigarettes) among older adult smokers at high risk for lung cancer. E-cigarettes use heated vapor to deliver nicotine. Information gained from this trial may help inform regulators of the potential risks and benefits of switching smokers at high risk for lung cancer to electronic cigarettes. This research also may help inform the Food and Drug Administration (FDA) how best to regulate e-cigarettes with the goal of improving public health.

Detailed description

PRIMARY OBJECTIVE: I. To characterize the effects of switching from combustible cigarettes (CCs) to e-cigarettes (ECs) on product use, product acceptability, and reinforcement among adult daily CC smokers at high risk for lung cancer. EXPLORATORY OBJECTIVES: I. To characterize the effects of switching from CCs to ECs on biomarkers of inflammation and oxidative stress among adult daily CC smokers at high for lung cancer. II. To characterize metabolomic changes that result from switching from CCs to ECs among CC smokers at high risk for lung cancer. III. To character which factors moderate or mediate the effects of switching from CCs to ECs among CC smokers at high risk for lung cancer. Outline: Participants are assigned to switch to e-cigarettes.

Conditions

Interventions

TypeNameDescription
PROCEDUREParticipants will vape electronic cigarettes for 26 weeks.Participants will vape electronic cigarettes for 26 weeks.
DRUGNicotine ReplacementSmoke usual brand of cigarettes
DRUGNicotine ReplacementVape e-cigarettes

Timeline

Start date
2022-03-07
Primary completion
2026-10-17
Completion
2026-10-17
First posted
2021-12-03
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05144542. Inclusion in this directory is not an endorsement.

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer (NCT05144542) · Clinical Trials Directory